COMMUNIQUÉS West-GlobeNewswire

U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery

25/04/2018 - 13:00

Multinational study expected to include clinical sites in U.S. Israel and Europe, where study has been awarded an $8.7 million grant from European Horizon 2020 Program HAIFA, Israel, April 25, 2018 (GLOBE NEWSWIRE) -- [...]

Zynerba Pharmaceuticals Announces Twelve Month ZYN002 Data from STAR 2 Study in Patients with Focal Seizures at the 2018 Annual Meeting of the American Academy of Neurology (AAN)

25/04/2018 - 13:00

Continued Improvement in Seizure Control Seen in Adult Refractory Focal Seizure Patients Receiving ZYN002 through 12 Months of Open Label Exposure LOS ANGELES, April 25, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals [...]

Asterias Announces Clinical Grade Lot Released to Support Dosing of First Subjects in First Clinical Study of AST-VAC2

25/04/2018 - 13:00

-Release of clinical grade lot of AST-VAC2 is key step in Cancer Research UK’s initiation of clinical study in Non-Small Cell Lung Cancer - FREMONT, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, [...]

Sharps Compliance Reports Fiscal 2018 Third Quarter Results

25/04/2018 - 12:55

Quarterly revenue of $9 . 4 million increased 10% over the prior year third quarter Unused Medication solutions business increased 111%; represents over 20% of total Company billings Route-based business increased 15% [...]

Avivagen Announces OxC-beta™ Purchase Order with New Customer

25/04/2018 - 12:30

OTTAWA, April 25, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”) is a life sciences corporation focused on developing and commercializing products for livestock, [...]

PCI Biotech: Publication of prospectus summary for transfer of listing to Oslo Børs

25/04/2018 - 12:28

Oslo (Norway), 25 th April 2018 - Reference is made to the stock exchange announcement made on 25 April 2018 regarding PCI Biotech Holding ASA ("PCI Biotech" or the "Company") being approved for listing on Oslo Børs as [...]

Financial calendar 2019

25/04/2018 - 12:11

Read the full announcement in the attached file Attachment 2018_17_Financial_calendar_EN

Natus Medical Announces First Quarter Financial Results

25/04/2018 - 12:05

Reports record first quarter revenue of $128.6 million Reports first quarter GAAP loss per share of $0.10 and non-GAAP earnings per share of $0.24 PLEASANTON, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Natus Medical [...]

Integra LifeSciences Reports First Quarter 2018 Financial Results

25/04/2018 - 12:00

Revenue Increased 38.1% to $357.1 million; Organic Revenue Increased 3.0% Reported EPS of $0.14; Adjusted EPS of $0.58 Company Raises Full-Year Total Revenue and EPS Guidance PLAINSBORO, N.J., April 25, 2018 (GLOBE [...]

INSYS Therapeutics to Report First Quarter 2018 Results on May 8

25/04/2018 - 12:00

PHOENIX, April 25, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

HealthLynked Corp. Announces Expansion of Its Sales Team into New Key Markets

25/04/2018 - 11:00

NAPLES, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK), improving healthcare through its advanced personal health record and patient engagement platform, today announced the expansion of its [...]

Notice of annual general meeting in Xbrane Biopharma AB

25/04/2018 - 08:31

The shareholders of Xbrane Biopharma AB, reg. no. 556749-2375, (the " Company "), are hereby convened to the annual general meeting to be held on Thursday 24 May 2018, at 17.30 p.m. at Baker McKenzie's preemies at [...]

Shire plc : Shire announces revised proposal and extension of PUSU deadline to 8 May 2018

25/04/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]

Shire plc : Rule 2.9 Announcement

25/04/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 25 April 2018 [...]

Interim report for the first three months of 2018

25/04/2018 - 07:57

Read the full announcement in the attached file Attachment 2018_16_Q12018_CompanyAnnouncement_FINAL_EN

Nicox : Ouverture d'un bureau de développement aux Etats-Unis, à Research Triangle Park en Caroline du Nord

25/04/2018 - 07:30

Communiqué de presse Nicox : Ouverture d'un bureau de développement aux Etats-Unis, à Research Triangle Park en Caroline du Nord Les activités de développement de Nicox, en croissance aux Etats-Unis, sont transférées [...]

Nicox: :Opening of U.S. Development Office in Research Triangle Park, North Carolina

25/04/2018 - 07:30

Press Release Nicox: Opening of U.S. Development Office in Research Triangle Park, North Carolina Company to relocate its growing U.S. development operations to the North Carolina biotech hub in Research Triangle Park [...]

Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home

25/04/2018 - 07:16

FocalView is a first-of-its-kind app designed to modernize ophthalmic clinical trials, making them more accessible and flexible Using patients' self-recorded measurements, FocalView aims to enable more sensitive trial [...]

Targovax presentation at ChinaBio Partnering Forum 2018

25/04/2018 - 07:01

Oslo, Norway, 25 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumours, have today presented at the ChinaBio Partnering Forum 2018. [...]